Healthcare & Life Sciences

OmnilinX Therapeutics AG

Switzerland
Sign in to unlock

About

OmnilinX Therapeutics AG is a biotechnology company developing therapeutics that modulate nuclear receptors to treat metabolic and inflammatory diseases.

Explore OmnilinX Therapeutics AG's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing